We then investigated the pharmacological antagonism of TAAR1 on glucose tolerance and insulin resistance in antibiotics-treated mice induced by gut dysbiosis including R. gnavus and fecal microbiota from IBS patients with high tryptamine and phenethylamine levels as well as high TyG index. Here, TAAR1 is linked to irritable bowel syndrome.